Company Search:
Advanced Search
Sponsored Links
Valeant Pharmaceuticals International Inc Company Snapshot
Valeant Pharmaceuticals International Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valeant Pharmaceuticals International Inc with three other pharmaceutical manufacturers in North America: Mylan NV of the United States (2017 sales of $11.91 billion ), Regeneron Pharmaceuticals Incorporated of the United States ($5.87 billion of which 100% was Research & Development), and Zoetis Inc which is also based in the United States ($5.31 billion of which 50% was International).

Sales Analysis. Valeant Pharmaceuticals International Inc reported sales of C$11.30 billion (US$8.62 billion) for the year ending December of 2017. This represents a decrease of 11.6% versus 2016, when the company's sales were C$12.78 billion. Contributing to the drop in overall sales was the 29.6% decline in U.S. Diversified Products Segment, from C$2.54 billion to C$1.78 billion. There were also decreases in sales in Branded Rx Segment (down 22.9% to C$3.21 billion) . However, these declines were partially offset by the increase in sales of Bausch + Lomb / International Segment (up 3.6% to C$6.31 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Valeant Pharmaceuticals International Inc
  Stock Performance Chart for Valeant Pharmaceuticals International Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 21.86
(Figures in Canadian Dollars)
1 Week 10.7%   13 Weeks -7.8%  
4 Weeks -13.9%   52 Weeks 48.5%  
Valeant Pharmaceuticals International Inc Key Data:
  Ticker: VRX Country: Canada
  Exchanges: NYSE TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 11,298,016,200
(Year Ending Jan 2018).
Employees: 20,700
  Currency: Canadian Dollars Market Cap: 7,622,769,275
  Fiscal Yr Ends: December Shares Outstanding: 348,708,567
  Share Type: Common Closely Held Shares: 3,171,221
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.